How many insider trades does FilingIQ track for APMD?

FilingIQ tracks 104 Form 4 insider transactions for APMD (Apnimed, Inc.), covering filings from Jul 30, 2026 onwards. 104 of those were filed in the last 90 days.

Are APMD insiders net buyers or net sellers?

Across the full Form 4 history for APMD, 2 transactions (2%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does APMD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is APMD in?

Apnimed, Inc. (APMD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $949.99M.

APMD insider trading

NasdaqGS Healthcare

Apnimed, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

104

Last 90 days

104

Buys / sells

2% / 0%

Market cap

$949.99M

About Apnimed, Inc.

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Company website: apnimed.com

APMD insider activity at a glance

FilingIQ has scored 104 insider transactions for APMD since Jul 30, 2026. The most recent filing in our index is dated Aug 3, 2036.

Across the full history, 2 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on APMD insider trades is 56.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live APMD trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 967

UNITED THERAPEUTICS Corp

APLS 271

Apellis Pharmaceuticals, Inc.

BLLN 208

BillionToOne, Inc.

KYMR 200

Kymera Therapeutics, Inc.

GH 195

Guardant Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for APMD?: FilingIQ tracks 104 Form 4 insider transactions for APMD (Apnimed, Inc.), covering filings from Jul 30, 2026 onwards. 104 of those were filed in the last 90 days.
Are APMD insiders net buyers or net sellers?: Across the full Form 4 history for APMD, 2 transactions (2%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does APMD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is APMD in?: Apnimed, Inc. (APMD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $949.99M.

Methodology & sources

Every APMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.